DEXCOM, INC. Debt Securities Available For Sale Excluding Accrued Interest Current
DEXCOM, INC. (DXCM) had Debt Securities Available For Sale Excluding Accrued Interest Current of $704.80 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent · last filed 2026-07-30
- 2026-06-30: Debt Securities Available For Sale Excluding Accrued Interest Current $704.80M.
- 2026-03-31: Debt Securities Available For Sale Excluding Accrued Interest Current $1.08B.
- 2025-12-31: Debt Securities Available For Sale Excluding Accrued Interest Current $1.08B.
- 2025-09-30: Debt Securities Available For Sale Excluding Accrued Interest Current $1.41B.
| Period end | Debt Securities Available For Sale Excluding Accrued Interest Current |
|---|---|
| 2026-06-30 | $704.80M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $1.08B 10-Q · filed 2026-04-30 |
| 2025-12-31 | $1.08B 10-Q · filed 2026-07-30 |
| 2025-09-30 | $1.41B 10-Q · filed 2025-10-30 |
| 2025-06-30 | $1.59B 10-Q · filed 2025-07-30 |
| 2024-12-31 | $1.73B 10-K · filed 2026-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |